Remix Therapeutics
The GCP Quality Assurance candidate will manage the development, maintenance, and oversight of Good Clinical Practice activities for company-sponsored clinical trials. This role ensures quality and compliance with Standard Operating Procedures, regulatory requirements, and industry standards across all clinical operations. The position involves providing guidance on risk management, conducting audits, and overseeing corrective actions to maintain regulatory adherence.
Headquarters
Watertown, Massachusetts, United States
Company Size
51-200 employees
Founded
2018
Remix Therapeutics is a clinical-stage biotechnology company developing small molecule therapies that modulate RNA processing to address disease drivers. The company's proprietary REMaster™ platform designs small molecules that harness cellular machineries to control RNA processing and modulate expression of disease-driving mRNAs and proteins, including historically undruggable targets. Its lead program, REM-422, is a first-in-class orally available small molecule mRNA degrader targeting MYB, with programs spanning oncology and other indications of high unmet medical need.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Remix Therapeutics.
Remix Therapeutics names Mythili Koneru as chief medical officer By Investing.com
Jan 6, 2026
Quality Assurance
Systimmune
Senior Manager, Quality Assurance GCP
Crinetics Pharmaceuticals
Director, GCP Quality Assurance
Acadia Pharmaceuticals Inc.
(Sr.) Manager, GCP Quality Assurance
Aurabiosciences
Senior Quality Assurance and Control Associate - Clinical Research
Baylor College of Medicine
Associate Director, GCP Quality Assurance
Olema Oncology